Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry

Jacquelyn Spano, Sean Ryan, Carlos Milla
European Respiratory Journal 2020 56: 4315; DOI: 10.1183/13993003.congress-2020.4315
Jacquelyn Spano
Stanford University, Palo Alto, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jmzirbes@stanford.edu
Sean Ryan
Stanford University, Palo Alto, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Milla
Stanford University, Palo Alto, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Objectives: The lung clearance index at 2.5 of starting concentration (LCI2.5) from Nitrogen multiple breath washout (MBW) has demonstrated sensitivity to early lung disease in Cystic Fibrosis (CF). Our study aims to evaluate if the LCI2.5 can identify lung disease progression in children with CF with normal lung function by spirometry.

Methods: We have enrolled 57 children with CF (mean age 10.3 + 3, range 6 - 18 years; 22 boys, 35 girls) into a longitudinal study that evaluates spirometry, MBW and patient reported outcomes at clinical encounters. Our main endpoint is FEV1 decline over one year.

Results: At baseline these children demonstrated normal parameters (mean FVC 99.2 + 20 %-pred., FEV1 94 + 21 %-pred., FEV1/FVC ratio 0.84 + 0.12; BMI 61 + 24 %-ile), with no significant differences between boys and girls (p > 0.25 for all). However, by LCI there was evidence for airway disease (Mean 9.4 units + 2.6) and with no differences between boys and girls (p = 0.5).

At baseline modest correlation was found between LCI and FEV1%-pred. (r 0.45, p = 0.001). During follow up, on average no significant change in FEV1 was noted (p = 0.57). However, there was an inverse correlation between baseline LCI and FEV1 decline (-2.5 %-pred./year for every unit of LCI2.5, p= 0.0001) and between change in LCI2.5 and FEV1 decline (-2.0 %-pred./year for every unit of increase in LCI2.5, p < 0.0001).

Conclusion: The LCI2.5 from MBW identifies children with subsequent decline in FEV1. One unit increase in LCI seems to be a strong indicator of lung disease activity.

Funding Source: US CFF MILLA17A0

  • Children
  • Chronic diseases
  • Measurement properties

Footnotes

Cite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 4315.

This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2020
Previous
Back to top
Vol 56 Issue suppl 64 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry
Jacquelyn Spano, Sean Ryan, Carlos Milla
European Respiratory Journal Sep 2020, 56 (suppl 64) 4315; DOI: 10.1183/13993003.congress-2020.4315

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry
Jacquelyn Spano, Sean Ryan, Carlos Milla
European Respiratory Journal Sep 2020, 56 (suppl 64) 4315; DOI: 10.1183/13993003.congress-2020.4315
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Omics-based tracking of P. aeruginosa persistence in CF
  • Hyperglycaemia in cystic fibrosis adversely affects BK channel function
  • Assessment lung function changes in cystic fibrosis using 129Xe MRI
Show more Cystic fibrosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society